TGF-β 1 and smad7 in the regulation of IBD

Mucosal Immunology

Volumn 1, Issue , 2008, Pages 50-53

  Monteleone, G ^a   Boirivant, M ^b   Pallone, F ^a   MacDonald, T T ^c  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; ANTISENSE OLIGONUCLEOTIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; SMAD2 PROTEIN; SMAD3 PROTEIN; SMAD6 PROTEIN;

ANIMAL; DISEASE MODEL; ENTERITIS; HUMAN; IMMUNOLOGY; METABOLISM; REVIEW; SIGNAL TRANSDUCTION; ANTIINFLAMMATORY ACTIVITY; COLITIS; CROHN DISEASE; CYTOKINE PRODUCTION; DIGESTIVE SYSTEM INFLAMMATION; IMMUNE RESPONSE; MUCOSA INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; ULCERATIVE COLITIS; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATORY BOWEL DISEASES; SIGNAL TRANSDUCTION; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 54349127897     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2008.55     Document Type: Review

References (19)

1. Podolsky, D. K. Inflammatory bowel disease. N. Engl. J. Med. 347, 417-429 (2002).
2. Bouma, G. & Strober, W. The immunological and genetic basis of inflammatory bowel disease. Nat. Rev. Immunol. 3, 521-533 (2003).
3. Kulkarni, A. B. & Karlsson, S. Transforming growth factor-β1 knockout mice. A mutation in one cytokine gene causes a dramatic inflammatory disease. Am. J. Pathol. 143, 3-9 (1993).
4. Goreli, L. & Flavell, R. A. Transforming growth factor-β in T-cell biology. Nat. Rev. Immunol. 2, 46-53 (2002).
5. Neurath, M. F. et al. Experimental granulomatous colitis in mice is abrogated by induction of TGF-β---mediated oral tolerance. J. Exp. Med. 183, 2605-2616 (1996).
6. Boirivant, M., Fuss, I. J., Chu, A. & Strober, W. Oxazolone colitis: a murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J. Exp. Med. 188, 1929-1939 (1998).
7. Powrie, F., Carlino, J., Leach, M. W., Mauze, S. & Coffman, R. L. A critical role for transforming growth factor-β but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RBlow CD4+ T cells. J. Exp. Med. 183, 2669-2674 (1996).
8. Heldin, C.-H., Kohei, M. & ten Dijke, P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471 (1997).
9. Yang, X. et al. Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T-cell responsiveness to TGF-β. EMBO J. 18, 1280-1291 (1999).
10. Di Sabatino, A. et al. Blockade of transforming growth factor-β upregulates T-box transcription factor T-bet, and increases T-helper-cell type 1 cytokine and matrix metalloproteinase-3 production in the human gut mucosa. Gut 57, 605-612 (2008).
11. Monteleone, G. et al. Blocking Smad7 restores TGF-β1 signaling in chronic inflammatory bowel disease. J. Clin. Invest. 108, 601-609 (2001).
12. Babyatsky, M. W., Rossiter, G. & Podolsky, D. K. Expression of transforming growth factors alpha and beta in colonic mucosa in inflammatory bowel disease. Gastroenterology 110, 975-984 (1996).
13. Nakao, A. et al. Identification of Smad7, a TGF-β-inducible antagonist of TGF-β signalling. Nature 389, 631-635 (1997).
14. Monteleone, G. et al. A failure of transforming growth factor-β 1 negative regulation maintains sustained NF-κB activation in gut inflammation. J. Biol. Chem. 279, 3925-3932 (2004).
15. Monteleone, G. et al. Induction and regulation of Smad7 in the gastric mucosa of patients with Helicobacter pylori infection. Gastroenterology 126, 674-682 (2004).
16. Benahmed, M. et al. Inhibition of TGF-β signaling by IL-15, a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 132, 994-1008 (2007).
17. Monteleone, G., Pallone, F. & MacDonald, T. T. Smad7 in TGF-β-mediated negative regulation of gut inflammation. Trends Immunol. 25, 513-517 (2004).
18. Monteleone, G. et al. Post-transcriptional regulation of Smad7 in the gut of patients with inflammatory bowel disease. Gastroenterology 129, 1420-1429 (2005).
19. Boirivant, M. et al. Inhibition of Smad7 with a specific antisense oligonucleotide facilitates TGF-β1-mediated suppression of colitis. Gastroenterology 131, 1786-1798 (2006).